Published in Prog Neuropsychopharmacol Biol Psychiatry on August 28, 2013
Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacol Biochem Behav (2014) 0.84
Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys. Neuropsychopharmacology (2015) 0.83
Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders. Curr Top Behav Neurosci (2016) 0.82
Effects of 7-day repeated treatment with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in male rhesus monkeys. Drug Alcohol Depend (2016) 0.76
Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder. Ann N Y Acad Sci (2016) 0.76
Agmatine attenuates the discriminative stimulus and hyperthermic effects of methamphetamine in male rats. Behav Pharmacol (2016) 0.75
Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment. Behav Pharmacol (2016) 0.75
Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend (2004) 2.97
Psychiatric symptoms in methamphetamine users. Am J Addict (2004) 2.76
Measures of Effect Size for Comparative Studies: Applications, Interpretations, and Limitations. Contemp Educ Psychol (2000) 1.76
The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav (2004) 1.67
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry (2007) 1.61
Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther (1992) 1.50
Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther (2003) 1.40
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2005) 1.39
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology (2007) 1.38
Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci (1989) 1.32
Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol (1997) 1.29
Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole. J Clin Psychopharmacol (2011) 1.22
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology (2005) 1.21
Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol (1998) 1.21
Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol (2001) 1.19
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther (1998) 1.19
A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health (2006) 1.16
Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry (1996) 1.14
Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) (2000) 1.12
Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol (2004) 1.12
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend (2002) 1.03
Aripiprazole. CNS Drugs (2002) 1.02
Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav (2007) 1.01
High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav (1997) 1.00
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend (2006) 1.00
A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis. Int J Psychiatry Clin Pract (2012) 0.98
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder. Psychopharmacology (Berl) (2009) 0.96
Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Exp Clin Psychopharmacol (2008) 0.96
The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology (Berl) (1995) 0.95
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction (2013) 0.95
Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther (1999) 0.95
Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors. J Pharmacol Exp Ther (2004) 0.94
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol (2008) 0.92
Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol (2010) 0.91
Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex. Neurosci Lett (2005) 0.87
Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis. Drug Alcohol Depend (2012) 0.84
Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine. Exp Clin Psychopharmacol (2006) 0.84
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacol (2010) 0.83
Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend (2002) 3.15
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci (2010) 1.45
Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl) (2006) 1.40
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2005) 1.39
Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem (2005) 1.34
Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control. J Psychopharmacol (2005) 1.31
The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav (2006) 1.29
Methylphenidate increases cigarette smoking. Psychopharmacology (Berl) (2005) 1.23
Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole. J Clin Psychopharmacol (2011) 1.22
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology (2005) 1.21
Bouts of responding: the relation between bout rate and the rate of variable-interval reinforcement. J Exp Anal Behav (2004) 1.18
Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend (2002) 1.12
Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol (2004) 1.12
A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology (Berl) (2007) 1.11
Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend (2003) 1.09
Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2004) 1.08
Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des (2013) 1.08
Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther (2008) 1.06
Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction (2006) 1.04
Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. Eur J Pharmacol (2010) 1.03
Fixation time is a sensitive measure of cocaine cue attentional bias. Addiction (2014) 1.02
Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. Drug Alcohol Depend (2007) 1.02
Alternative reinforcer response cost impacts cocaine choice in humans. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.02
Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav (2007) 1.01
Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol Biochem Behav (2010) 1.01
Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. Behav Cogn Neurosci Rev (2003) 1.00
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend (2006) 1.00
Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Exp Clin Psychopharmacol (2007) 0.98
Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend (2003) 0.97
Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Exp Clin Psychopharmacol (2005) 0.96
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp Clin Psychopharmacol (2006) 0.94
Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology (2007) 0.94
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. Am J Drug Alcohol Abuse (2007) 0.93
Human sex differences in d-amphetamine self-administration. Addiction (2010) 0.92
Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol (2010) 0.91
Alcohol choice and amphetamine effects in light and moderate drinkers. Alcohol Clin Exp Res (2003) 0.89
Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction (2012) 0.89
Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend (2004) 0.89
Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) (2011) 0.89
Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite (2004) 0.89
d-Amphetamine-induced enhancement of inhibitory mechanisms involved in visual search. Exp Clin Psychopharmacol (2005) 0.89
Similar discriminative-stimulus effects of D-amphetamine in women and men. Pharmacol Biochem Behav (2007) 0.88
Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology (Berl) (2003) 0.88
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research. Expert Rev Clin Pharmacol (2014) 0.87
Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology (Berl) (2010) 0.87
Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers. Am J Drug Alcohol Abuse (2008) 0.86
Pilot Safety Evaluation of Varenicline for the Treatment of Methamphetamine Dependence. J Exp Pharmacol (2009) 0.86
Cocaine improves inhibitory control in a human model of response conflict. Exp Clin Psychopharmacol (2005) 0.86
Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug Alcohol Depend (2011) 0.85
Drug-related stimuli impair inhibitory control in cocaine abusers. Drug Alcohol Depend (2013) 0.85
Methylphenidate increases choice of cigarettes over money. Nicotine Tob Res (2010) 0.85
Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women. Psychopharmacology (Berl) (2011) 0.84
The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys. Pharmacol Biochem Behav (2006) 0.84
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacol Biochem Behav (2005) 0.84
The influence of acute varenicline administration on smoking and eating behavior in humans. Pharmacol Biochem Behav (2008) 0.84
Methamphetamine self-administration in humans during D-amphetamine maintenance. J Clin Psychopharmacol (2014) 0.84
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. Am J Drug Alcohol Abuse (2008) 0.83
Discriminative-stimulus effects of triazolam in women and men. Am J Drug Alcohol Abuse (2006) 0.83
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacol (2010) 0.83
Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Psychopharmacology (Berl) (2014) 0.82
Differential effects in humans after repeated administrations of zolpidem and triazolam. Am J Drug Alcohol Abuse (2003) 0.81
Stimulant-induced changes in smoking and caloric intake: influence of rate of onset. Pharmacol Biochem Behav (2009) 0.81
Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. Drug Alcohol Depend (2008) 0.81
Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans. J Psychopharmacol (2002) 0.81
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial. Drug Alcohol Depend (2012) 0.80
Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. Am J Drug Alcohol Abuse (2014) 0.80
Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs (2011) 0.80
Alternative reinforcer response cost impacts methamphetamine choice in humans. Pharmacol Biochem Behav (2012) 0.80
Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior? Behav Pharmacol (2013) 0.80
Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans. Biol Psychiatry (2002) 0.80
Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacol Biochem Behav (2011) 0.79
Influence of escalating alternative reinforcer values on cigarette choice. Behav Processes (2011) 0.79
Behavioral and physiological effects of cocaine in humans following triazolam. Pharmacol Biochem Behav (2003) 0.78
Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans. Behav Pharmacol (2013) 0.78
Amphetamine self-administration in light and moderate drinkers. Alcohol Clin Exp Res (2010) 0.78
Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. J Clin Psychopharmacol (2016) 0.78
Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy. J Addict Med (2016) 0.77
Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules. Hum Psychopharmacol (2014) 0.77
Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users. Psychopharmacology (Berl) (2013) 0.77
Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis. J Exp Anal Behav (2015) 0.75
Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women. Behav Pharmacol (2011) 0.75
Moving beyond the cannabis controversy into the world of the cannabinoids. Int Rev Psychiatry (2009) 0.75
Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity. Am J Drug Alcohol Abuse (2010) 0.75